Breakthrough Pain in Children with Cancer

Journal of Pain and Symptom Management

Volumn 34, Issue 2, 2007, Pages 209-216

  Friedrichsdorf, Stefan J ^a   Finney, Deborah ^a   Bergin, Mary ^a   Stevens, Michael ^a   Collins, John J ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

breakthrough pain; Cancer; child; neuropathic pain

Indexed keywords

FENTANYL; HYDROMORPHONE; MORPHINE; OPIATE DERIVATIVE; OXYCODONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; AUSTRALIA; BOLUS INJECTION; CANCER PAIN; CHILDHOOD CANCER; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; MALE; MOOD; PATIENT CONTROLLED ANALGESIA; PEDIATRIC HOSPITAL; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; STRUCTURED INTERVIEW;

ADOLESCENT; ANALGESICS, OPIOID; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NEOPLASMS; PAIN; PAIN MEASUREMENT; PREVALENCE; PROSPECTIVE STUDIES;

EID: 34547095508     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.10.022     Document Type: Article

References (27)

1. Portenoy R.K., and Hagen N.A. Breakthrough pain: definition, prevalence and characteristics in patients with cancer pain. Pain 4 (1990) 273-281
2. Portenoy R.K., Payne D., and Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81 (1999) 129-134
3. Zeppetella G., O'Doherty C.A., and Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage 20 (2000) 87-92
4. Mercadante S., Maddaloni S., Roccella S., and Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain 50 (1992) 151-155
5. Bruera E., Schoeller T., Wenk R., et al. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage 10 (1995) 348-355
6. Coluzzi P.H., Schwartzberg L., Conjoy Jr. J.D., et al. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 91 (2001) 123-130
7. Collins J.J., and Weisman S.J. Management of pain in childhood cancer. In: Schechter N.L., Berde C.B., and Yaster M. (Eds). Pain in infants, children, and adolescents (2003), Lippincott, Williams & Wilkins, Philadelphia 517-538
8. Flogegard H., and Ljungman G. Characteristics and adequacy of intravenous morphine infusions in children in a paediatric oncology setting. Med Pediatric Oncol 40 (2003) 233-238
9. Hicks C.L., Baeyer C.L., Spafford P.A., van Korlaar I., and Goodenough B. The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain 93 (2001) 173-183
10. Reynolds C.R., and Paget K.D. Factor analysis of the revised Children's Manifest Anxiety Scale for blacks, whites, males, and females with a national normative sample. J Consult Clin Psychol 49 (1981) 352-359
11. Hodges K.K., Siegel L.J., Mullins L., and Griffin N. Factor analysis of the Children's Depression Inventory. Psychol Rep 53 (1983) 759-763
12. Helsel W.J., and Matson J.L. The assessment of depression in children: the internal structure of the Child Depression Inventory (CDI). Behav Res Ther 22 (1984) 289-298
13. Mercadante S. Breakthrough pain in cancer patients. Pain Clin Updates 14 (2006) 1-4
14. Jacobson S.J., Kopecky E.A., Joshi P., and Babul N. Randomised trial of oral morphine for painful episodes of sickle-cell disease in children. Lancet 350 (1997) 1358-1361
15. Radbruch L., Loick G., Schulzeck S., et al. Intravenous titration with morphine for severe cancer pain: report of 28 cases. Clin J Pain 15 (1999) 173-178
16. Fisher K., Stiles C., and Hagen N.A. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study. J Pain Symptom Manage 28 (2004) 619-625
17. Enting R.H., Mucchiano C., Oldenmenger W.H., et al. The "pain pen" for breakthrough cancer pain: a promising treatment. J Pain Symptom Manage 29 (2005) 213-217
18. Payne R., Coluzzi P., Hart L., et al. Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. J Pain Symptom Manage 22 (2001) 575-583
19. Hanks G.W., Nugent M., Higgs C.M., and Busch M.A. OTFC Multicentre Study Group. Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study. Palliat Med 18 (2004) 698-704
20. Lennernas B., Hedner T., Holmberg M., et al. Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain. Br J Clin Pharmacol 59 (2005) 249-253
21. Zeppetella G. An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study. J Pain Symptom Manage 20 (2000) 253-258
22. Pavis H., Wilcock A., Edgecombe J., et al. Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer. J Pain Symptom Manage 24 (2002) 598-602
23. Fitzgibbon D., Morgan D., Dockter D., Barry C., and Kharasch E.D. Initial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthrough pain in cancer patients. Pain 106 (2003) 309-315
24. Portenoy R.K., Payne R., Coluzzi P., et al. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain 79 (1999) 303-312
25. Trelis J., Perez-Hernandez C., Sanchez-Dominguez F., et al. Citrato de fentanilo oral transmucosa en el tratamiento del dolor irruptivo en pacientes con cáncer en España: resultados del estudio EDIPAD (Oral transmucosal fentanyl citrate in the treatment of breakthrough pain in patients with cancer in Spain: Results of EPIPAD study). Rev Soc Esp Dolor 11 (2004) 184-196
26. Carr D.B., Goudas L.C., Denman W.T., et al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain 108 (2004) 17-27
27. Tsui B.C.H., Davies D., Desai S., and Malherbe S. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma. J Pediatr Hematol Oncol 26 10 (2004) 678-680